Finance

Lists
STMN:SWX
Straumann Holding AG
CHF 94.64
-0.40%
(-0.38) 1D
Sep 4, 2:44:37 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for STMN...
Open
CHF 95.02
High
CHF 95.56
Low
CHF 94.64
Mkt. cap
15.09B
Avg. vol.
360.23K
Volume
63.84K
Dividend
1.06%
Quarterly dividend
CHF 0.25
Ex-dividend date
Apr 21, 2026
P/E ratio
40.82
52-wk high
CHF 109.80
52-wk low
CHF 73.02
EPS
CHF 2.32
Shares outstanding
159.46M
No. of employees
12K
Open
CHF 95.02
High
CHF 95.56
Low
CHF 94.64
Mkt. cap
15.09B
Avg. vol.
360.23K
Volume
63.84K
Dividend
1.06%
Quarterly dividend
CHF 0.25
Ex-dividend date
Apr 21, 2026
P/E ratio
40.82
52-wk high
CHF 109.80
52-wk low
CHF 73.02
EPS
CHF 2.32
Shares outstanding
159.46M
No. of employees
12K
News stories
From web sources and news partners
Profile
Straumann Group is a Swiss company based in Basel manufacturing dental implants and specialized in related technologies. The group researches, develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry. The Straumann Group also offers services to the dental profession worldwide, including training and education, which is provided in collaboration with the International Team for Implantology and the Instituto Latino Americano de Pesquisa e Ensino Odontológico. Its products and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners. Wikipedia
About Straumann Holding AG
CEOGuillaume Daniellot | Guillaume Daniellot
Employees11.6K
Founded1954
HeadquartersBasel, Basel City, Switzerland
SectorMedical device
Website-
Last report
Aug 19, 2026
Fiscal period
Q2 2026
EPS / Est. (CHF)
CHF 1.64 / -
0.00%miss
Revenue / Est. (CHF)
1.38B / 698.90M
+97.38%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
628.60M
628.60M
689.73M
689.73M
Cost of goods sold
201.43M
201.43M
203.84M
203.84M
Cost of revenue
201.43M
201.43M
203.84M
203.84M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
280.83M
280.83M
316.62M
316.62M
Operating expense
277.79M
277.79M
312.52M
312.52M
Total operating expenses
479.22M
479.22M
516.36M
516.36M
Operating income
149.38M
149.38M
173.38M
173.38M
Other non operating income
-3.58M
-3.58M
-2.93M
-2.93M
EBT including unusual items
81.29M
81.29M
156.66M
156.66M
EBT excluding unusual items
136.50M
136.50M
154.39M
154.39M
Income tax expense
21.37M
21.37M
31.32M
31.32M
Effective tax rate
26.29%
26.29%
19.99%
19.99%
Other operating expenses
-3.04M
-3.04M
-4.10M
-4.10M
Net income
59.74M
59.74M
124.85M
124.85M
Net profit margin
9.50%
9.50%
18.10%
18.10%
Earnings per share
-
-
-
-
Interest and investment income
48.95M
48.95M
18.66M
18.66M
Interest expense
-38.43M
-38.43M
-31.47M
-31.47M
Net interest expenses
10.52M
10.52M
-12.81M
-12.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
158.16M
158.16M
214.24M
214.24M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps